Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,126.06
(
1.20%
)
US TECH 100
25,958.80
(
1.33%
)
Dow Jones
49,447.43
(
1.88%
)
Brent Oil
91.78
(
-0.95%
)
Bitcoin
74,386.90
(
0.71%
)
News Focus
News Focus
Post# of 517435
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next

Hoskuld

Send PM Follow Ignore
Followers 35
Posts 4005
Boards Moderated 0
Alias Born 08/07/2022

Hoskuld

Re: kevindenver post# 503411

Friday, 10/17/2025 9:35:15 AM

Friday, October 17, 2025 9:35:15 AM

Post# of 517435
This has been such a management failure. It is the only massive mistake that Anavex made and continues to make: failing to run the correct number of trials that are properly powered. It is so shocking that, 18 months after opening acknowledging this shortcoming at the ASM in 2024, they STILL fail to correct this behavior. I am unhappy that this company has such incredibly good therapeutic assets but they squander their opportunities to capitalize on them. SMH.
Public Reply Private Reply New Post
Keep Last Read
Replies (3) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (3) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote
Recent AVXL News
More AVXL News